Amoxapine Dimer (USP) | CAS 1216608-66-0 - Request Quote
Amoxapine Dimer (USP)
| SZ CAT No: | SZ-A048026 |
| CAS No | 1216608-66-0 |
| Mol.F. | C30H22Cl2N4O2 |
| Mol.Wt. | 541.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Amoxapine Dimer (USP) is chemically 1,4-Bis(2-chlorodibenzo[b,f][1,4]oxazepine-11-yl)piperazine (as per USP). Amoxapine Dimer (USP) is supplied with detailed characterization data compliant with regulatory guideline. Amoxapine Dimer (USP) can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Amoxapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1216608-66-0
Purchase 1216608-66-0
Order 1216608-66-0
Enquire 1216608-66-0
price of 1216608-66-0
1216608-66-0 Supplier
1216608-66-0 Manufacturer
1216608-66-0 Exporter
buy high quality Amoxapine Dimer (USP)
Purchase Amoxapine Dimer (USP)
Amoxapine Dimer (USP) suppliers
Amoxapine Dimer (USP) manufacturers
Amoxapine Dimer (USP) price
Order Amoxapine Dimer (USP)
Enquire Amoxapine Dimer (USP)
Amoxapine Dimer (USP) cost
Amoxapine Dimer (USP) Supplier
Amoxapine Dimer (USP) Distributor
Amoxapine Dimer (USP) for Method Validation
Amoxapine Reference Standard
Amoxapine Dimer (USP) for ANDA Filing
Amoxapine Dimer (USP) for Forced Degradation Studies
Amoxapine Dimer (USP) Identification Standards
Amoxapine Dimer (USP) for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.